Physicians Financial Services’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.05M Sell
23,841
-75
-0.3% -$17.5K 1.51% 15
2026
Q1
$5.85M Buy
23,916
+437
+2% +$102K 1.6% 15
2025
Q4
$4.86M Sell
23,479
-120
-0.5% -$23.7K 1.3% 20
2025
Q3
$4.38M Sell
23,599
-185
-0.8% -$31.7K 1.19% 24
2025
Q2
$3.63M Sell
23,784
-932
-4% -$143K 1.08% 26
2025
Q1
$4.1M Sell
24,716
-145
-0.6% -$22.7K 1.3% 21
2024
Q4
$3.6M Sell
24,861
-170
-0.7% -$26.3K 1.09% 26
2024
Q3
$4.06M Sell
25,031
-725
-3% -$116K 1.26% 23
2024
Q2
$3.77M Sell
25,756
-191
-0.7% -$28.4K 1.22% 21
2024
Q1
$4.11M Sell
25,947
-1,071
-4% -$170K 1.45% 18
2023
Q4
$4.24M Sell
27,018
-1,147
-4% -$176K 1.61% 17
2023
Q3
$4.39M Sell
28,165
-30
-0.1% -$4.95K 1.8% 14
2023
Q2
$4.67M Buy
28,195
+51
+0.2% +$8.23K 1.83% 12
2023
Q1
$4.36M Buy
28,144
+94
+0.3% +$15.2K 1.84% 11
2022
Q4
$4.96M Sell
28,050
-349
-1% -$60.3K 2.23% 10
2022
Q3
$4.64M Sell
28,399
-741
-3% -$125K 2.24% 10
2022
Q2
$5.17M Buy
29,140
+832
+3% +$148K 2.3% 8
2022
Q1
$5.02M Sell
28,308
-102
-0.4% -$17.4K 1.92% 10
2021
Q4
$4.86M Sell
28,410
-53
-0.2% -$8.68K 1.8% 11
2021
Q3
$4.6M Sell
28,463
-175
-0.6% -$29.9K 1.86% 11
2021
Q2
$4.72M Sell
28,638
-1,039
-4% -$172K 1.93% 8
2021
Q1
$4.88M Buy
29,677
+3,961
+15% +$641K 2.09% 9
2020
Q4
$4.05M Sell
25,716
-2,856
-10% -$421K 1.95% 10
2020
Q3
$4.25M Buy
28,572
+161
+0.6% +$23.8K 2.12% 9
2020
Q2
$4M Buy
28,411
+1,810
+7% +$264K 2.21% 8
2020
Q1
$3.49M Sell
26,601
-955
-3% -$135K 2.4% 7
2019
Q4
$4.02M Sell
27,556
-49
-0.2% -$6.65K 2.17% 9
2019
Q3
$3.57M Sell
27,605
-1,007
-4% -$133K 2.04% 15
2019
Q2
$3.98M Buy
28,612
+200
+0.7% +$27.7K 2.34% 9
2019
Q1
$3.97M Buy
28,412
+501
+2% +$67.1K 2.47% 8
2018
Q4
$3.6M Buy
27,911
+5,678
+26% +$792K 2.62% 7
2018
Q3
$3.07M Sell
22,233
-74
-0.3% -$9.83K 2.11% 10
2018
Q2
$2.71M Buy
22,307
+298
+1% +$37.2K 2.03% 13
2018
Q1
$2.81M Sell
22,009
-2,246
-9% -$304K 2.23% 10
2017
Q4
$3.39M Sell
24,255
-69
-0.3% -$9.61K 2.59% 6
2017
Q3
$3.16M Hold
24,324
2.59% 6
2017
Q2
$3.22M Sell
24,324
-1,512
-6% -$193K 2.73% 5
2017
Q1
$3.22M Sell
25,836
-649
-2% -$77.5K 2.78% 4
2016
Q4
$3.31M Buy
26,485
+60
+0.2% +$6.93K 2.71% 4
2016
Q3
$3.12M Sell
26,425
-85
-0.3% -$10.3K 2.6% 4
2016
Q2
$3.22M Buy
26,510
+135
+0.5% +$15.3K 2.81% 4
2016
Q1
$2.85M Buy
26,375
+138
+0.5% +$14.3K 2.58% 5
2015
Q4
$2.69M Buy
+26,237
New +$2.64M 2.49% 6

Other funds holding JNJ

Physicians Financial Services's JNJ Position: Q2 2026 in Review

Physicians Financial Services reduced its Johnson & Johnson (JNJ) stake by 0.31% in Q2 2026, selling an estimated $17.5K and leaving 23,841 shares worth $6.05M. The position accounts for 1.51% of the portfolio, ranked #15.

Physicians Financial Services first reported a position in JNJ in Q4 2015 and has held it in 43 quarters since. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Physicians Financial Services held 23,841 shares of Johnson & Johnson worth $6.05M as of Q2 2026.
  • Physicians Financial Services sold 75 Johnson & Johnson shares in Q2 2026, an estimated $17.5K.
  • Johnson & Johnson made up 1.51% of Physicians Financial Services's portfolio in Q2 2026, its #15 holding.
  • Physicians Financial Services first reported a position in Johnson & Johnson in Q4 2015 and has held it in 43 quarters since.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Physicians Financial Services's 13F filing for Q2 2026, filed 21 Jul 2026.